FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361 | -95.5% | 139 | -95.7% | 0.00% | – |
| Q2 2022 | $8,000 | +60.0% | 3,259 | +180.9% | 0.00% | – |
| Q4 2021 | $5,000 | -76.2% | 1,160 | -56.3% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | -12.5% | 2,654 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | +41.2% | 3,015 | +93.5% | 0.00% | – |
| Q1 2021 | $17,000 | – | 1,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,140,000 | 2.34% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $3,887,000 | 1.96% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,340,000 | 1.91% |
| Sio Capital Management, LLC | 260,448 | $649,000 | 0.24% |
| Orbimed Advisors | 3,224,770 | $8,030,000 | 0.15% |
| Artal Group S.A. | 750,000 | $1,868,000 | 0.10% |
| TPG GP A, LLC | 2,551,794 | $6,354,000 | 0.10% |
| Perceptive Advisors | 1,052,445 | $2,621,000 | 0.08% |
| Rock Springs Capital Management LP | 809,854 | $2,017,000 | 0.06% |
| FEDERATED HERMES, INC. | 3,124,100 | $7,779,000 | 0.02% |